NEW YORK, Sept. 11 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb (NYSE: BMY - News) today announced that its Board of Directors has elected R. Sanders Williams, M.D. to the Board, effective today. Dr. Williams was appointed to the newly-formed Science and Technology Committee of the Board of Directors.
